MultiPlan Corporation (NYSE: MPLN-WT) Stock Competitors & Peer Comparison
See MPLN-WT's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MPLN-WT and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MPLN-WT | $0.00 | -70.00% | 625.2M | N/A | N/A | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $59.13 | -2.91% | 11.6B | 47.69 | $1.24 | N/A |
| BTSGU | $195.51 | -3.30% | 11.5B | 176.79 | $1.11 | N/A |
| TEM | $64.04 | -9.41% | 11.2B | -128.08 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $96.37 | +3.19% | 8.1B | 22.52 | $4.28 | N/A |
| TXG | $61.54 | -5.10% | 7.8B | -104.31 | -$0.59 | N/A |
| HNGE | $87.35 | -5.92% | 6.8B | 46.70 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
MPLN-WT vs GEHCV Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas GEHCV's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, MPLN-WT is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
MPLN-WT vs BTSG Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, BTSG has a market cap of 11.6B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while BTSG trades at $59.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 47.69. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, MPLN-WT is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
MPLN-WT vs BTSGU Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, BTSGU has a market cap of 11.5B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while BTSGU trades at $195.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas BTSGU's P/E ratio is 176.79. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, MPLN-WT is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
MPLN-WT vs TEM Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, TEM has a market cap of 11.2B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while TEM trades at $64.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas TEM's P/E ratio is -128.08. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to TEM's ROE of -0.55%. Regarding short-term risk, MPLN-WT is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
MPLN-WT vs SGFY Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, MPLN-WT is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
MPLN-WT vs HQY Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, HQY has a market cap of 8.1B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while HQY trades at $96.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 22.52. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to HQY's ROE of +0.11%. Regarding short-term risk, MPLN-WT is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
MPLN-WT vs TXG Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, TXG has a market cap of 7.8B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while TXG trades at $61.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas TXG's P/E ratio is -104.31. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to TXG's ROE of -0.09%. Regarding short-term risk, MPLN-WT is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
MPLN-WT vs HNGE Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, HNGE has a market cap of 6.8B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while HNGE trades at $87.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas HNGE's P/E ratio is 46.70. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, MPLN-WT is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
MPLN-WT vs RCM Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to RCM's ROE of +0.00%. Regarding short-term risk, MPLN-WT is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check RCM's competition here
Waystar Holding Corp. (NASDAQ: WAY)
MPLN-WT vs WAY Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, WAY has a market cap of 5B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while WAY trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas WAY's P/E ratio is 17.38. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to WAY's ROE of +0.04%. Regarding short-term risk, MPLN-WT is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check WAY's competition here
Doximity, Inc. (NYSE: DOCS)
MPLN-WT vs DOCS Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while DOCS trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 17.47. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, MPLN-WT is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check DOCS's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
MPLN-WT vs HTFL Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, HTFL has a market cap of 4.1B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while HTFL trades at $47.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas HTFL's P/E ratio is -23.77. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, MPLN-WT is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
MPLN-WT vs ONEM Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, MPLN-WT is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
MPLN-WT vs PRVA Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, PRVA has a market cap of 2.6B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while PRVA trades at $20.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 99.00. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, MPLN-WT is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check PRVA's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
MPLN-WT vs NXGN Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, MPLN-WT is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check NXGN's competition here
Omnicell, Inc. (NASDAQ: OMCL)
MPLN-WT vs OMCL Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, OMCL has a market cap of 1.5B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while OMCL trades at $33.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas OMCL's P/E ratio is 17.32. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, MPLN-WT is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check OMCL's competition here
Omada Health (NASDAQ: OMDA)
MPLN-WT vs OMDA Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while OMDA trades at $23.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas OMDA's P/E ratio is 338.43. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, MPLN-WT is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
MPLN-WT vs AGTI Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, MPLN-WT is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check AGTI's competition here
Certara, Inc. (NASDAQ: CERT)
MPLN-WT vs CERT Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CERT trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CERT's P/E ratio is 20.87. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CERT's ROE of -0.07%. Regarding short-term risk, MPLN-WT is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
MPLN-WT vs GDRX Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while GDRX trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 11.03. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, MPLN-WT is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
MPLN-WT vs TDOC Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while TDOC trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -6.57. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, MPLN-WT is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check TDOC's competition here
HealthStream, Inc. (NASDAQ: HSTM)
MPLN-WT vs HSTM Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, HSTM has a market cap of 858.3M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while HSTM trades at $29.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 40.81. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, MPLN-WT is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check HSTM's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
MPLN-WT vs CCLDO Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, MPLN-WT is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CCLDO's competition here
Phreesia, Inc. (NYSE: PHR)
MPLN-WT vs PHR Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, PHR has a market cap of 750.4M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while PHR trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas PHR's P/E ratio is 43.36. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to PHR's ROE of +0.03%. Regarding short-term risk, MPLN-WT is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check PHR's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
MPLN-WT vs SOPH Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, SOPH has a market cap of 682.9M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while SOPH trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -7.33. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, MPLN-WT is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check SOPH's competition here
Claritev Corporation (NYSE: CTEV)
MPLN-WT vs CTEV Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CTEV has a market cap of 669.3M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CTEV trades at $39.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -2.31. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, MPLN-WT is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CTEV's competition here
Accolade, Inc. (NASDAQ: ACCD)
MPLN-WT vs ACCD Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, MPLN-WT is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
MPLN-WT vs SHCR Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, MPLN-WT is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
MPLN-WT vs EVH Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, EVH has a market cap of 518M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while EVH trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas EVH's P/E ratio is 35.42. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to EVH's ROE of -0.99%. Regarding short-term risk, MPLN-WT is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check EVH's competition here
NRC Health (NASDAQ: NRC)
MPLN-WT vs NRC Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, NRC has a market cap of 492.4M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while NRC trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 26.65. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to NRC's ROE of +0.48%. Regarding short-term risk, MPLN-WT is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
MPLN-WT vs SLGC Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, MPLN-WT is more volatile compared to SLGC. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
MPLN-WT vs SLGCW Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, MPLN-WT is more volatile compared to SLGCW. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
MPLN-WT vs TBRG Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is 9.37. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, MPLN-WT is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
MPLN-WT vs MPLN Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, MPLN-WT is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
MPLN-WT vs SY Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, SY has a market cap of 314.9M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while SY trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas SY's P/E ratio is -7.27. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to SY's ROE of -0.16%. Regarding short-term risk, MPLN-WT is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
MPLN-WT vs TRHC Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, MPLN-WT is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
MPLN-WT vs SMFR Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, MPLN-WT is more volatile compared to SMFR. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
MPLN-WT vs SPOK Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, SPOK has a market cap of 222.4M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while SPOK trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 17.75. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, MPLN-WT is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
MPLN-WT vs AMWL Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, AMWL has a market cap of 202.2M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while AMWL trades at $11.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -2.69. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, MPLN-WT is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check AMWL's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
MPLN-WT vs LFMDP Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, LFMDP has a market cap of 156.9M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while LFMDP trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas LFMDP's P/E ratio is -709.24. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, MPLN-WT is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check LFMDP's competition here
LifeMD, Inc. (NASDAQ: LFMD)
MPLN-WT vs LFMD Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, LFMD has a market cap of 151.9M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while LFMD trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas LFMD's P/E ratio is -6.28. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, MPLN-WT is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check LFMD's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
MPLN-WT vs OPRX Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, OPRX has a market cap of 149.2M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while OPRX trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is 7.29. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, MPLN-WT is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check OPRX's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
MPLN-WT vs CPSI Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, MPLN-WT is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
MPLN-WT vs HCAT Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, HCAT has a market cap of 117.5M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while HCAT trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is 7.95. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, MPLN-WT is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
MPLN-WT vs AUGX Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, MPLN-WT is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
MPLN-WT vs CCLD Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CCLD has a market cap of 105.8M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CCLD trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is 9.58. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, MPLN-WT is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
MPLN-WT vs WORX Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -6.40. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to WORX's ROE of -0.35%. Regarding short-term risk, MPLN-WT is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for MPLN-WT.Check WORX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
MPLN-WT vs DH Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, DH has a market cap of 84.7M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while DH trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas DH's P/E ratio is 3.09. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to DH's ROE of -0.79%. Regarding short-term risk, MPLN-WT is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
MPLN-WT vs FORA Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -24.11. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to FORA's ROE of -0.17%. Regarding short-term risk, MPLN-WT is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
MPLN-WT vs CCLDP Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, MPLN-WT is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
MPLN-WT vs SNCE Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, MPLN-WT is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
MPLN-WT vs AKLI Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, MPLN-WT is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
MPLN-WT vs SHLT Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, MPLN-WT is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMD)
MPLN-WT vs ONMD Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, ONMD has a market cap of 33M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while ONMD trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -3.62. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, MPLN-WT is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check ONMD's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
MPLN-WT vs SHCRW Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, MPLN-WT is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
MPLN-WT vs ONMDW Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, ONMDW has a market cap of 31.1M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas ONMDW's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, MPLN-WT is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
MPLN-WT vs STRM Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.40. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to STRM's ROE of -0.65%. Regarding short-term risk, MPLN-WT is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
MPLN-WT vs RNLX Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, MPLN-WT is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
MPLN-WT vs LIFW Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, MPLN-WT is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check LIFW's competition here
Babylon Holdings Limited (NYSE: BBLN)
MPLN-WT vs BBLN Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, MPLN-WT is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check BBLN's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
MPLN-WT vs BFRG Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, BFRG has a market cap of 10.1M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while BFRG trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -1.18. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, MPLN-WT is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
MPLN-WT vs ETAO Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, MPLN-WT is more volatile compared to ETAO. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
MPLN-WT vs MGRX Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, MGRX has a market cap of 6.8M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while MGRX trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.30. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, MPLN-WT is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH-WT)
MPLN-WT vs UPH-WT Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, MPLN-WT is more volatile compared to UPH-WT. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
MPLN-WT vs UPH Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to UPH's ROE of -1.05%. Regarding short-term risk, MPLN-WT is more volatile compared to UPH. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check UPH's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
MPLN-WT vs PEARW Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, MPLN-WT is more volatile compared to PEARW. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
MPLN-WT vs PEAR Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, MPLN-WT is more volatile compared to PEAR. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
MPLN-WT vs OTRK Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.02. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, MPLN-WT is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
MPLN-WT vs CMAX Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, MPLN-WT is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
MPLN-WT vs BFRGW Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas BFRGW's P/E ratio is -0.92. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, MPLN-WT is more volatile compared to BFRGW. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check BFRGW's competition here
Aclarion, Inc. (NASDAQ: ACON)
MPLN-WT vs ACON Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while ACON trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.27. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to ACON's ROE of -0.59%. Regarding short-term risk, MPLN-WT is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
MPLN-WT vs LIFWZ Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, MPLN-WT is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check LIFWZ's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
MPLN-WT vs HCTI Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, HCTI has a market cap of 975.4K. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while HCTI trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.11. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, MPLN-WT is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
MPLN-WT vs VSEEW Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, MPLN-WT is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for MPLN-WT.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
MPLN-WT vs MSPRZ Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, MPLN-WT is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for MPLN-WT.Check MSPRZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
MPLN-WT vs VSEE Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, VSEE has a market cap of 245.6K. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while VSEE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -0.03. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, MPLN-WT is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check VSEE's competition here
Akerna Corp. (NASDAQ: KERN)
MPLN-WT vs KERN Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to KERN's ROE of -0.20%. Regarding short-term risk, MPLN-WT is more volatile compared to KERN. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
MPLN-WT vs KERNW Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, MPLN-WT is more volatile compared to KERNW. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
MPLN-WT vs LIFWW Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, MPLN-WT is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
MPLN-WT vs CMAXW Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, MPLN-WT is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
MPLN-WT vs ZCMD Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, ZCMD has a market cap of 32.1K. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while ZCMD trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, MPLN-WT is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
MPLN-WT vs ACONW Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, ACONW has a market cap of 13.6K. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas ACONW's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, MPLN-WT is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check ACONW's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
MPLN-WT vs CHNG Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CHNG's P/E ratio is -152.72. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, MPLN-WT is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CHNG's competition here
NantHealth, Inc. (NASDAQ: NH)
MPLN-WT vs NH Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, NH has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas NH's P/E ratio is -0.12. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to NH's ROE of +0.35%. Regarding short-term risk, MPLN-WT is more volatile compared to NH. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check NH's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
MPLN-WT vs KURIU Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas KURIU's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, MPLN-WT is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check KURIU's competition here
CareCloud, Inc. (NASDAQ: MTBC)
MPLN-WT vs MTBC Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, MPLN-WT is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check MTBC's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
MPLN-WT vs IMS Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, IMS has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas IMS's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to IMS's ROE of +0.27%. Regarding short-term risk, MPLN-WT is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check IMS's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
MPLN-WT vs AFFX Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas AFFX's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, MPLN-WT is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check AFFX's competition here
Castlight Health, Inc. (NYSE: CSLT)
MPLN-WT vs CSLT Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CSLT's P/E ratio is -37.27. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, MPLN-WT is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CSLT's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
MPLN-WT vs SMFRW Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas SMFRW's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, MPLN-WT is more volatile compared to SMFRW. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check SMFRW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
MPLN-WT vs MSPRV Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas MSPRV's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to MSPRV's ROE of N/A. Regarding short-term risk, MPLN-WT is more volatile compared to MSPRV. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check MSPRV's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
MPLN-WT vs NAVA Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas NAVA's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, MPLN-WT is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for MPLN-WT.Check NAVA's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
MPLN-WT vs CHNGU Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CHNGU's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, MPLN-WT is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
MPLN-WT vs CNVY Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CNVY's P/E ratio is -71.50. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, MPLN-WT is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
MPLN-WT vs MTBCP Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, MPLN-WT is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
MPLN-WT vs MTBCO Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas MTBCO's P/E ratio is N/A. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, MPLN-WT is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check MTBCO's competition here
Cerner Corporation (NASDAQ: CERN)
MPLN-WT vs CERN Comparison September 2026
MultiPlan Corporation (NYSE: MPLN-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MPLN-WT stands at 625.2M. In comparison, CERN has a market cap of 0. Regarding current trading prices, MPLN-WT is priced at $0.00 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MPLN-WT currently has a P/E ratio of N/A, whereas CERN's P/E ratio is 55.84. In terms of profitability, MPLN-WT's ROE is +1.40%, compared to CERN's ROE of +0.14%. Regarding short-term risk, MPLN-WT is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for MPLN-WT.Check CERN's competition here